Jesus G. Berdeja, MD^1,2, Tara B. Gregory, MD^1,3, Edward A. Faber, DO^1,4*, Jeffrey V. Matous, MD^1,3, Lowell L. Hart, MD^1,5, Joseph R. Mace, MD^1,6*, James D. Peyton, MD^1,2*, James H. Essell, MD^1,4, Edward R. Arrowsmith, MD, MPH^1,7 and Ian W. Flinn, MD, PhD^1,2

¹Sarah Cannon Research Institute, Nashville, TN
²Tennessee Oncology, PLLC, Nashville, TN
³Colorado Blood Cancer Institute, Denver, CO
⁴Oncology Hematology Care, Cincinnati, OH
⁵Florida Cancer Specialists, Ft. Myers, FL
⁶Florida Cancer Specialists, St Petersburg, FL
⁷Tennessee Oncology, PLLC, Chattanooga, TN

Rakesh Popat, MBBS, PhD^1*, Sarah R Brown^2*, Louise M Flanagan^2*, Andrew Hall^2*, Bhuvan Kishore, MBBS, FRPATH, MRCP^3*, Matthew Streetly⁴, Heather E Oakervee⁵, Simon L. Hallam^5*, Matthew Smith, MBBS, MA, MRCP, MRCPath, MD^5*, Kwee L Yong, MBChB, PhD^6*, Gordon Cook, MD, PhD⁷ and James D. Cavenagh, MD⁵

¹Department of Haematology, University College London Hospitals, London NW1 2PG, United Kingdom
²Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
³Heart of England NHS Trust, Birmingham, United Kingdom
⁴Haematology, Guy's & St. Thomas' NHS Foundation Trust, London, United Kingdom
⁵Barts Health NHS Trust, London, United Kingdom
⁶University College London Hospitals NHS Foundation Trust, London, United Kingdom
⁷St James's University Hospital, Leeds, United Kingdom

Dan T. Vogl, MD¹, Noopur S. Raje, MD², Sundar Jagannath, MD³, Paul G. Richardson, MD⁴, Parameswaran Hari, MD, MRCP, MS⁵, Robert Z. Orlowski, Ph.D., M.D.⁶, Jeffrey Supko, PhD^7*, David Tamang, PhD^8*, Simon S Jones, PhD^8*, Catherine Wheeler, MD^8*, Robert J Markelewicz Jr., MD^8* and Sagar Lonial, MD^9,10

¹Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA
²Massachusetts General Hospital Cancer Center, Boston, MA
³Hematology and Medical Oncology, Mount Sinai Hospital, New York, NY
⁴Division of Hematologic Malignancy, Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁵Medical College of Wisconsin, Milwaukee, WI
⁶Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Massachusetts General Hospital, Boston
⁸Acetylon Pharmaceuticals, Inc., Boston
⁹Winship Cancer Institute, Emory University, Atlanta, GA
¹⁰Winship Cancer Institute of Emory University, Department of Hematology and Medical Oncology, Atlanta, GA

Sara Bringhen^1*, Davide Rossi, MD, PhD², Alessandra Larocca^1*, Paolo Corradini², Piero Galieni^2*, Alessandra Malfitano^1*, Simona Aschero^1*, Massimo Offidani², Anna Marina Liberati², Mariella Genuardi^1*, Gianluca Gaidano², Carmela Palladino^1*, Fabiana Gentilini^2*, Mario Boccadoro, MD¹, Pieter Sonneveld, MD, PhD³ and Antonio Palumbo¹

¹Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy
²Italian Multiple Myeloma Network, GIMEMA, Italy
³Department of Hematology, Erasmus MC, Rotterdam, Netherlands

Peter M. Voorhees¹, Brendan Weiss^2*, Saad Usmani^3*, Huaibao Feng^4*, Clarissa Uhlar^5*, Imran Khan^5*, Tahamtan Ahmadi^5* and Sagar Lonial, MD^6,7

¹Division of Hematology/Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC
²Division of Hematology & Oncology, Department of Medicine, Abramson Cancer Center and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
³Levine Cancer Institute/Carolinas Healthcare System, Charlotte, NC
⁴Janssen Research & Development, LLC, Raritan, NJ
⁵Janssen Research & Development, LLC, Spring House, PA
⁶Winship Cancer Institute, Emory University, Atlanta, GA
⁷Winship Cancer Institute of Emory University, Department of Hematology and Medical Oncology, Atlanta, GA

Larissa Higgins, MD^1*, Ronald S. Go, MD², Shaji Kumar, MD², S. Vincent Rajkumar², Francis Buadi, MD², Martha Q. Lacy, MD², Angela Dispenzieri, MD², David Dingli, MD, PhD, FRCP², John A. Lust, MD, PhD², Prashant Kapoor, MD², Robert A. Kyle, MD², Morie A. Gertz, MD² and Wilson I. Gonsalves, MD^2*

¹Galway University Hospital, Galway, Ireland
²Division of Hematology, Mayo Clinic, Rochester, MN

Guillemette Fouquet^1*, Lionel Karlin^2*, Margaret MACRO, MD^3*, Denis Caillot^4*, Murielle Roussel^5*, Bertrand Arnulf^6*, Brigitte Pégourie^7*, Marie-Odile Petillon^8*, Gerald Marit^9*, Claire Mathiot, MD^10*, Brigitte Kolb^11*, Anne-Marie Stoppa, MD¹², Sabine Brechignac, MD^13*, Philippe Rodon, MD¹⁴, Mamoun Dib^15*, Mourad Tiab, MD^16*, Laurence Legros, MD^17*, Anne Banos, MD^18*, Marc Wetterwald, MD, PhD^19*, Laurent Garderet, MD²⁰, Bruno Royer, MD^21*, Cyrille Hulin^22*, Lotfi Benboubker^23*, Olivier Decaux, MD, PhD^24*, Martine Escoffre^25*, Jean-Paul Fermand²⁶, Philippe Moreau^27*, Herve Avet-Loiseau, MD, PhD^28*, Michel Attal²⁹, Thierry Facon¹ and Xavier Leleu, MD, PhD³⁰

¹Maladies du Sang, Hôpital Claude Huriez, CHRU Lille, Lille, France
²Service d'Hématologie, Centre Hospitalier Lyon Sud, Pierre Bénite, France
³Hopital Cote De Nacre, Caen Cedex 9, France
⁴Hôpital du Bocage, Dijon, France
⁵Hopital Purpan, Toulouse, France
⁶Hôpital Saint Louis, Paris, France
⁷CHU de Grenoble - Hôpital Albert Michallon, Grenoble, France
⁸Service des Maladies du Sang, CHU Lille, Lille, France
⁹CHU, Bordeaux, France
¹⁰IFM, Paris, France
¹¹Hopital Robert Debre, Reims Cedex, France
¹²Institut Paoli Calmettes, Marseille, France
¹³Hematologie Clinique, Hopital Avicenne APHP Université Paris 13, Bobigny, France
¹⁴Hematology, Centre Hospitalier, Perigueux, France
¹⁵Hématologie - CHU - Hôpital du Bocage, Angers, France
¹⁶Hopital la Roche Sur Yon, La Roche Sur Yon Cedex 9, France
¹⁷Hematology department, Hopital Archet 1, CHU Nice, Nice, France
¹⁸Hematology Department, CH Cote basque, Bayonne, France
¹⁹CHD Dunkerque, Dunkerque, France
²⁰Hôpital Saint Antoine, Paris, France
²¹Hematology, Centre Hospitalier Universitaire, Amiens, France
²²Service Hematologie, CHRU Hopitaux de Brabois, NANCY CEDEX, France
²³CHU, Tours, France
²⁴Internal Medicine Department, CHU de Rennes, Rennes, France
²⁵CHU Rennes, Rennes, France
²⁶Service d'Immuno-Hematologie, Hopital Saint-Louis, APHP, Paris, France
²⁷University of Nantes, Nantes, France
²⁸Unit for Genomics in Myeloma, Institut Universitaire du Cancer, Toulouse, France
²⁹Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France
³⁰Service d'h, hopital la miletrie, POITIER, France

Meletios A. Dimopoulos¹, Efstathios Kastritis, MD^2*, Maria Roussou^2*, Erasmia Psimenou^2*, Maria Gavriatopoulou^2*, Magdalini Migkou^2*, Evangelos Eleutherakis-Papaiakovou^2*, Dimitrios Ziogas^2*, Ioannis Panagiotidis^2*, Despoina Fotiou^2*, Eftychia Kafantari^2*, Stavroula Giannouli^3*, Sofoklis Kontogiannis^2* and Evangelos Terpos²

¹National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
³Second Department of Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Steven P Treon, MD, PhD¹, Kirsten Meid, MPH^1*, Joshua Gustine, MPH^1*, Christopher J Patterson, MFA^1*, Jeffrey V. Matous, MD², Irene M. Ghobrial, MD³ and Jorge J Castillo, MD⁴

¹Bing Center for WM, Dana Farber Cancer Institute, Boston, MA
²Colorado Blood Cancer Institute, Denver, CO
³Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA
⁴Division of Hematologic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Philippe Moreau^1*, Antonio Palumbo², Paolo Corradini³, Michele Cavo^4*, Michel Delforge⁵, Katja C. Weisel^6*, Enrique M. Ocio, MD, PhD^7*, Annamaria Cafro^8*, Christoph Rollig^9*, Stefan Knop^10*, Felipe de Arriba^11*, Mathew Simcock^12*, Neil Miller^12*, Ana Slaughter^12*, Latisha Watkins^13*, Jennifer Herring^13*, Tsvetan Biyukov¹⁴, Teresa Peluso^14*, Mohamed H Zaki¹³ and Meletios A. Dimopoulos¹⁵

¹Nantes University Hospital, Hôtel‐Dieu, Nantes, France
²University of Torino, Torino, Italy
³Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
⁴Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
⁵University Hospital Leuven, Leuven, Belgium
⁶Hematology & Oncology, Department of Medicine, University Hospital Tuebingen, Tuebingen, Germany
⁷University Hospital of Salamanca, Salamanca, Spain
⁸Hospedale Niguarda Ca' Granda, Milan, Italy
⁹Universitätsklinikum TU, Dresden, Germany
¹⁰Department of Internal Medicine. II, Wuerzburg, Germany
¹¹Hospital General Universitario Morales Meseguer, Murcia
¹²Celgene International Sàrl, Boudry, Switzerland
¹³Celgene Corporation, Summit, NJ
¹⁴Celgene Corporation, Boudry, Switzerland
¹⁵National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Douglas W Sborov, MD, MS¹, Flavia Pichiorri, PhD, MSC^2*, Gerard J Nuovo, MD^3*, Don M Benson, MD, PhD⁴, Yvonne A. Efebera, MD, MPH⁵, Ashley E Rosko, MD⁴ and Craig C Hofmeister, MD, MPH⁴

¹Department of Internal Medicine, Hematology/Oncology fellowship, The Ohio State University, Columbus, OH
²CCC, Ohio State University, Columbus, OH
³Phylogeny Inc., Columbus, OH
⁴Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
⁵Comprehensive Cancer Center, The Ohio State University, Columbus, OH

Mark B Pepys, MD PhD FRS FMedSci^1*, Louise M Cookson, BSc^2*, Sharon V Barton, BSc MSc^2*, Alienor C Berges, PharmD^2*, Thirusha Lane, RN MSc^3*, David Hutt, BAppSc^3*, Marianna Fontana, MD^4*, James C Moon, MD^5*, Julian D Gillmore, MD PhD FRCP^4*, Ashutosh Wechalekar, MD FRCPath FRCP³, Philip N Hawkins, MD PhD FMedSci^4* and Duncan B Richards, DM FRCP^2*

¹Wolfson Drug Discovery Unit & NHS National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, University College London, London, United Kingdom
²GSK R&D, GlaxoSmithKline, Stevenage, United Kingdom
³NHS National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, University College London and Royal Free Hospital, London, United Kingdom
⁴National Amyloidosis Centre, University College London, London, United Kingdom
⁵UCL Institute of Cardiovascular Science and Barts Heart Centre, University College London, London, United Kingdom

Tineke Casneuf^1*, Andrew Lysaght^2*, Clare LeFave^3*, Jaime Bald^4*, Brendan Weiss^5*, Niels W.C.J. van de Donk⁶, Henk M. Lokhorst⁶, Tahamtan Ahmadi^4* and A. Kate Sasser^4*

¹Janssen Research & Development, Beerse, Belgium
²Immuneering Corp., Cambridge, MA
³LabConnect LLC, Seattle, WA
⁴Janssen Research & Development, LLC, Spring House, PA
⁵Division of Hematology & Oncology, Department of Medicine, Abramson Cancer Center and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
⁶Department of Hematology, VU University Medical Center, Amsterdam, Netherlands

Yvonne A. Efebera, MD, MPH¹, Ashley E Rosko, MD², Craig Hofmeister³, Joe Benner, BS^4*, Courtney Bakan, BS^4*, Kathleen Stamper, BS^4*, Tammy Lamb, CNP^4*, Devine Hollie, CNP^4*, Megan Sell, CNP^4*, David E. Avigan, MD⁵ and Don M Benson, MD, Ph.D^6*

¹Comprehensive Cancer Center, The Ohio State University, Columbus, OH
²Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
³Division of Hematology, Ohio State University Medical Center, Columbus, OH
⁴The Ohio State University, Division of Hematology, Columbus, OH
⁵Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
⁶The Ohio State University, department of Internal Medicine, Division of Hematology, Columbus

Abhisek Swaika, MBBS¹, Vivek Roy, MD², Zhuo Li, M.S^3*, Neha Sood, MD^1*, Kristina Laumann^4*, Amanda Shreders, MD¹, Joseph Mikhael, MD⁵, Shaji Kumar, MD⁶, Asher Alban Chanan-Khan, MD¹, Martha Q. Lacy, MD⁶ and Sikander Ailawadhi, MD¹

¹Division of Hematology & Oncology, Mayo Clinic, Jacksonville, FL
²Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL
³Division of Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville
⁴Mayo Clinic, Rochester, MN
⁵Division of Hematology, Mayo Clinic, Scottsdale Campus, Scottsdale, AZ
⁶Division of Hematology, Mayo Clinic, Rochester, MN

Kwee L Yong, MBChB, PhD^1*, Sarah Brown^2*, Samantha Hinsley^2*, Louise Flanagan^2*, Neil Rabin, MB, BS, PhD^3*, Karthik Ramasamy^4*, Jamie Cavenagh⁵, Roger G Owen⁶, Martin F Kaiser, MD^7*, Eric Low^8* and Catherine Williams^9*

¹Department of Haematology, UCL Cancer Institute, London, United Kingdom
²Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
³Department of Haematology, Universityy College London Hospitals, London, United Kingdom
⁴Department of Haematology, University of Oxford, Oxford, United Kingdom
⁵Dept. of Hematology, St. Bartholomew's Hospital, London, United Kingdom
⁶United Leeds Teaching Hospitals, Leeds, United Kingdom
⁷The Institute of Cancer Research, London, United Kingdom
⁸Myeloma UK, Edinburgh, United Kingdom
⁹Department of Haematology, Nottingham University Hospital, Nottingham, United Kingdom

Ilka Decker, MD, MS^1*, Oluchi C. Ukaegbu, MD^1*, Stacey A. Goodman, MD, MS^1*, Daniel J. Lenihan, MD^2*, Rebecca R Hung, MD^2*, Adetola A. Kassim, MD, MS¹, Shelton L. Harrell, MSN, ACNP-BC^1*, Kevin McDonagh, MD¹, Sharon E. Phillips, MSPH^3*, Kyle T Rawling^1*, Samuel M Rubinstein, MD^1*, Tarsheen K. Sethi, MD, MS¹ and Robert F Cornell, MD, MS¹

¹Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN
²Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN
³Department of Biostatistics, Division of Cancer Biostatistics, Vanderbilt University Medical Center, Nashville, TN

Majed Alahmadi, MBBS, FRCPC^1,2, Esther Masih-Khan, PhD^3*, Eshetu G Atenafu, M.Sc., P.Stat.^4*, Limore Arones^5*, Christine Chen, MD⁶, Vishal Kukreti, MD¹, Rodger Tiedemann, MBChB, PhD⁷, Suzanne Trudel, MD¹, Anca Prica, MD⁷ and Donna Reece¹

¹Princess Margaret Cancer Centre, Toronto, ON, Canada
²King Abdulaziz Medical City, Jeddah, Saudi Arabia
³Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁴Biostatistics Department, Princess Margaret Hospital, Toronto, ON, Canada
⁵Princess Margaret Cancer Centre, Toronto, Canada
⁶Princess Margaret Hospital, Toronto, ON, Canada
⁷Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada

Sharmilan Thanendrarajan, MD¹, Daisy V. Alapat, MD², Maurizio Zangari, MD¹, Carolina Schinke, MD^1*, Christoph Heuck, MD¹, Frits van Rhee, MD, PhD¹, Adam Rosenthal^3*, Joshua Epstein, DSc¹, Shmuel Yaccoby, PhD¹, Faith E Davies, MD¹, Gareth J Morgan, MD PhD¹ and Bart Barlogie, MD, PhD¹

¹Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR
²Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR
³Cancer Research And Biostatistics, Seattle, WA

Antonio Palumbo¹, Meletios A. Dimopoulos², Philippe Moreau^3*, Wee-Joo Chng⁴, Hartmut Goldschmidt⁵, Roman Hájek⁶, Thierry Facon⁷, Heinz Ludwig⁸, Ludek Pour, MD^9*, Ruben Niesvizky¹⁰, Albert Oriol, MD^11*, Laura Rosiñol^12*, Aleksandr Suvorov^13*, Gianluca Gaidano¹⁴, Tomas Pika^15*, Katja Weisel^16*, Vesselina Goranova-Marinova^17*, Heidi H. Gillenwater¹⁸, Nehal Mohamed^18*, Shibao Feng^18* and Douglas Joshua¹⁹

¹University of Torino, Torino, Italy
²National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
³University of Nantes, Nantes, France
⁴National University Cancer Institute, National University Health System, Singapore and Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
⁵Heidelberg Medical University, Heidelberg, Germany
⁶University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
⁷CHRU Lille Hopital Claude Huriez, Lille, France
⁸Department of Medicine I, Wilhelminenhospital, Wilhelminen Cancer Research Institute, Vienna, Austria
⁹University Hospital Brno, Brno, Czech Republic
¹⁰Weill Cornell Medical College/New York Presbyterian Hospital, New York, NY
¹¹Institut Català d’Oncologia, Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain
¹²Hospital Clínic de Barcelona, Barcelona, Spain
¹³First Republican Clinical Hospital of Udmurtia, Izhevsk, Russia
¹⁴Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
¹⁵University Hospital Olomouc, Olomouc, Czech Republic
¹⁶Universitatsklinikum Tubingen, Tubingen, Germany
¹⁷Hematology Clinic University Multiprofile Hospital for Active Treatment, Plovdiv, Bulgaria
¹⁸Onyx Pharmaceuticals, Inc., an Amgen subsidiary, South San Francisco, CA
¹⁹Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia

Victor H Jimenez-Zepeda, MD¹, Christopher P. Venner, MD², Andrew Belch³, Irwindeep Sandhu, MD⁴, Tatiana Nikitina^2*, Joanne D Hewitt, RN, BSN, NP^5*, Peter Duggan, MD⁶, Paola Neri, MD, PhD⁷, Fariborz Rashid-Kolvear, PhD^8* and Nizar J Bahlis, MD⁷

¹University of Calgary, Division of Hematology, Calgary, AB, Canada
²Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
³Cross Cancer Institute, Edmonton, AB, Canada
⁴Department of Medicine, Division of Hematology, University of Alberta, Edmonton, AB, Canada
⁵Nursing, Cross Cancer Institute, Edmonton, AB, Canada
⁶Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, AB, Canada
⁷University of Calgary, Southern Alberta Cancer Research Institute, Calgary, AB, Canada
⁸Calgary Lab Services, Calgary, AB, Canada

Victor H Jimenez-Zepeda, MD¹, Peter Duggan, MD², Paola Neri, MD, PhD³ and Nizar J Bahlis, MD³

¹University of Calgary, Division of Hematology, Calgary, AB, Canada
²Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, AB, Canada
³University of Calgary, Southern Alberta Cancer Research Institute, Calgary, AB, Canada

John R Jones, MD^1,2*, David A Cairns^3*, Rachel Sigsworth^3*, Corinne Collett^3*, Charlotte Pawlyn, MB BChir^1,2*, Alina Striha^3*, Lorenzo Melchor, PhD^2*, Martin F Kaiser, MD^1,2*, Mark T Drayson, MD, PhD^4*, Faith E Davies, MD^2,5, Walter M Gregory^3*, Kevin Boyd, MD^1*, Roger G Owen⁶, Graham H Jackson, MD⁷ and Gareth J Morgan, MD, PhD^2,5

¹Department of Haematology, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom
²The Institute of Cancer Research, London, United Kingdom
³Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
⁴Clinical Immunology, School of Immunity & Infection, University of Birmingham, Birmingham, United Kingdom
⁵Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR
⁶United Leeds Teaching Hospitals, Leeds, United Kingdom
⁷Department of Haematology, University of Newcastle, Newcastle-upon-Tyne, United Kingdom

Maria-Victoria Mateos, MD, PhD^1,2, Joaquín Martínez-López^3*, Miguel T Hernandez^4*, Enrique M Ocio^5*, Laura Rosiñol, MD PhD^6*, Rafael Martinez, MD^7*, Ana Isabel Teruel, MD^8*, Norma C Gutierrez^9*, María-Luisa Martín^10*, Albert Oriol, MD^11*, Joan Bargay, MD^12*, Enrique Bengoechea^13*, Yolanda Gonzalez, MD^14*, Jaime Perez de Oteyza^15*, Mercedes Gironella^16*, Cristina Encinas^17*, Carmen Cabrera^18*, Bruno Paiva, PhD^19*, Maria Teresa Cedena^10*, Noemi Puig, MD, PhD^20*, Joan Blade, MD PhD⁶, Juan José Lahuerta^10* and Jesus San Miguel, MD PhD^19*

¹IBMCC (University of Salamanca-CSIC), Salamanca, Spain
²Hospital Universitario de Salamanca-IBSAL, Salamanca, Spain
³Hospital Universitario 12 de Octubre, Madrid, Spain
⁴Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain
⁵Complejo Asistencial Universitario de Salamanca (IBSAL) y Centro de Investigación del Cáncer (IBMCC-CSIC). Universidad de Salamanca, Salamanca, Spain
⁶Hospital Clinic de Barcelona, Barcelona, Spain
⁷Hospital Clinico, Madrid, Spain
⁸Hospital Clinico de Valencia, Valencia, Spain
⁹Hematology, Hospital Universitario de Salamanca-IBSAL, Salamanca, Spain
¹⁰Hospital 12 de Octubre, Madrid, Spain
¹¹Institut Català d’Oncologia, Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain
¹²Department of Hematology. Hospital Son Llatzer, Palma de Mallorca, Spain
¹³Hospital de Donostia, San Sebastian, Spain
¹⁴Haematology, Institut d’Oncologia Dr Josep Trueta de Girona, Girona, Spain
¹⁵Hospital Universitario Sanchinarro, Madrid, Spain
¹⁶Hospital Universitari Vall dHebron, Barcelona, Spain
¹⁷Instituto de Investigacion Sanitaria Gregorio Marañón (IiSGM), Hospital General Universitario Gregorio Marañón,, Madrid, Spain
¹⁸Hospital San Pedro de Alcántara, Cáceres, Spain
¹⁹Centro de Investigación Médica Aplicada, University of Navarra, Clínica Universidad de Navarra, Pamplona, Spain
²⁰Instituto Biosanitario de Salamanca (IBSAL) and Cancer Research Centre (Instituto de Biología Molecular y Celular del Cáncer; CSIC-USAL), Salamanca, Spain

Antonella Chillemi, PhD^1*, Valeria Quarona^1*, Andrea Zito^1*, Fabio Morandi, PhD^2*, Danilo Marimpietri^2*, Massimiliano Cuccioloni, PhD^3*, Oldham J Robert^4*, Cragg S Mark, PhD^4*, Marina Bolzoni, PhD^5*, Denise Toscani, PhD^5*, Vito Pistoia, MD², Nicola Giuliani, MD, PhD⁶, Alberto L Horenstein, PhD^7,8*, Kate Sasser, PhD^9* and Fabio Malavasi, MD^7,8*

¹Laboratory of Immunogenetics, Department of Medical Sciences, University of Torino, Torino, Italy
²Laboratory of Oncology, Istituto Giannina Gaslini, Genova, Italy
³School of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy
⁴Antibody & Vaccine Group, Cancer Sciences Unit, University of Southampton, Southampton General Hospital, Southampton, United Kingdom
⁵Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy
⁶Myeloma Unit, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy
⁷Laboratory of Immunogenetics, University of Torino, Torino, Italy
⁸CeRMS, University of Torino, Torino, Italy
⁹Heme Disease Area Stronghold, Janssen Pharmaceutical R&D, Spring House, PA

Arash Latifoltojar, MB BS, MSc, MPhil^1*, Kwee L Yong, MBChB, PhD^2*, Margaret Hall-Craggs, BA, MB BS, MD^3*, Neil Rabin, MB, BS, PhD^4*, Rakesh Popat, MBBS, PhD^5*, Alan Bainbridge^6*, Magdalena Sokolska^6*, Nikolaos Dikaios^3*, Shirley D'Sa, MD, FRCP, FRCPath^7*, Ali Rismani, MBBS^7* and Shonit Punwani, Mb BS, BSc, PhD^1*

¹Centre for Medical Imaging, University College London, London, United Kingdom
²Department of Haematology, UCL Cancer Institute, London, United Kingdom
³Centre for Medical Imaging, University College London Hospitals, London, United Kingdom
⁴Department of Haematology, Universityy College London Hospitals, London, United Kingdom
⁵Department of Haematology, University College London Hospitals, London NW1 2PG, United Kingdom
⁶Medical Physics and Bioengineering, University College London Hospitals, London, United Kingdom
⁷Department of Haematology, University College London Hospitals, London, United Kingdom

Deepak Perumal, PhD^1*, Alessandro Lagana', PhD^2*, Alex Rubinsteyn, PhD^2*, John P Finnigan Jr., BS^1*, Pei-Yu Kuo, MS^1*, Violetta V Leshchenko, PhD^1*, Ajai Chari, MD¹, Hearn Jay Cho, MD, PhD¹, Sundar Jagannath, MD¹, Joel Dudley, PhD^2*, Jeff Hammerbacher, BA^2*, Eric Schadt, PhD^2*, Nina Bhardwaj, MD, PhD^1* and Samir Parekh, MD¹

¹Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
²Genomics and Genetic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY

Matthew W Jenner, MD^1*, Avie-Lee Tillotson^2*, Sarah R Brown^2*, Louise M Flanagan^2*, Debbie Sherratt^2*, Charlotte Pawlyn, MB BChir^3*, Cathy Williams^4* and Faith E Davies, MD⁵

¹Southampton General Hospital, Southampton, United Kingdom
²Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
³The Institute of Cancer Research, London, United Kingdom
⁴Centre for Clinical Haematology, Nottingham University Hospitals, Nottingham, United Kingdom
⁵Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR

David S Siegel, MD, PhD¹, Gary Schiller², Kevin Song³, Richy Agajanian^4*, Keith Stockerl-Goldstein⁵, Hakan Kaya^6*, Michael Sebag⁷, Frederic J Reu⁸, Jorge Mouro^9*, Michael Sturniolo^9*, Shankar Srinivasan^9*, Anjan Thakurta^9*, Yasir Nagarwala⁹ and Nizar J Bahlis, MD¹⁰

¹John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
²University of California, Los Angeles, CA
³Hematology, Vancouver General Hospital, Vancouver, BC, Canada
⁴The Oncology Institute of Hope and Innovation, Downey, CA
⁵Washington University School of Medicine, St Louis, MO
⁶Cancer Care Northwest, Spokane, Washington, WA
⁷Division of Hematology, McGill University Health Center, McGill University, Montreal, QC, Canada
⁸Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
⁹Celgene Corporation, Summit, NJ
¹⁰University of Calgary, Southern Alberta Cancer Research Institute, Calgary, AB, Canada

Jumei Shi, M.D., Ph.D.¹, Guang Yang^2*, Yuanyuan Kong^2*, Minjie Gao^2*, Yi Tao^2*, Yiwen Zhang^2* and Xiaosong Wu^2*

¹Department of Hematology, Shanghai 10th People's Hospital, Tongji University School of Medicine, Shanghai, China
²Department of Hematology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, China

Jianling Fan, MD^1*, Jian Hou, MD, PhD^1*, Juan Du, MD, PhD^1*, Lina Jin^1*, Lihui Peng^1*, Baoan Chen, PhD, Professor², Hao Xi^1*, Hui Zhang^1*, Hua Jiang, MD^1*, Fan Zhou^3* and Weijun Fu, MD^1*

¹Department of Hematology, The Myeloma & Lymphoma Center, Changzheng Hospital, The Second Military Medical University, Shanghai, China
²Department of Hematology and Oncology, The affiliated Zhongda Hospital, Medical School, Southeast University, Nanjing, China
³Department of Hematology, Zhabei Center Hospital, Shanghai, China

Alejandra Leivas, PhD student^1*, Antonio Pérez-Martínez, MD, PhD^2*, María Jesús Blanchard, MD^3*, Estela Martín Clavero, MD^1*, Dario Campana, MD, PhD⁴, Juan José Lahuerta, MD PhD^5* and Joaquín Martínez-López, MD, PhD^1*

¹Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain
²Department of Pediatrics, Hospital Universitario La Paz, Madrid, Spain
³Department of Hematology, Hospital universitario Ramón y Cajal, Madrid, Spain
⁴Department of Pediatrics, National University of Singapore, Singapore, Singapore
⁵Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain

Cristina Gasparetto, MD¹, Michael Green, MD^2*, Anandgopal Srinivasan, Medical Student^3*, Yubin Kang, MD.⁴, David A. Rizzieri, MD², Carlos Decastro, MD^1*, Louis F. Diehl, MD¹, Anne Beaven, MD^1*, Zighuo Li, PhD^1*, Arati V. Rao, MD^5,6, Anderson Garrett^1*, Sascha Tuchman, MD⁷ and Gwynn D. Long, MD¹

¹Duke University Medical Center, Durham, NC
²Dept. of Medicine, Div. of Hematological Malignancies & Cellular Therapy, Duke University Medical Center, Durham, NC
³School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom
⁴Medicine, duke university, durham, NC
⁵Medicine, Division of Cellular Therapy, Duke University, Durham, NC
⁶Duke Cancer Institute, Duke University, Durham, NC
⁷Duke University, Durham, NC

Laurent Garderet, MD¹, Emmanuelle Polge^2*, mor Seny Gueye^3*, Chaima Kellil^4*, Jeanny Guelongo Okouango Ova^4*, Eric Beohou^5*, Myriam Labopin, MD^6* and Mohamad Mohty, MD, PhD⁷

¹Hôpital Saint Antoine, Paris, France
²EBMT Department of Haematology, Saint Antoine Hospital, Paris, France
³University Hospital saint antoine, Paris, France
⁴University Hospital Saint Antoine, Paris, France
⁵Hôpital Saint-Antoine, EBMT, Acute Leukemia Working Party and Registry, Paris, France
⁶Service d’Hématologie et Thérapie Cellulaire, Hôpital Saint-Antoine, Paris, France
⁷Department of Haemotology, Saint Antoine Hospital, Paris, France